4.6 Review

A pharmacogenetic strategy for immunosuppression based on the CYP3A5 genotype

期刊

TRANSPLANTATION
卷 85, 期 2, 页码 163-165

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/TP.0b013e3181609054

关键词

pharmacogenetics; immunosuppression; tacrolimus; CYP3A5; transplantation

向作者/读者索取更多资源

Pharmacogenetics has the potential to complement therapeutic drug monitoring in achieving target blood concentrations of the immunosuppressive drugs during the critical early period after transplantation when adequate drug exposure is essential to prevent rejection. The most attractive candidate for a pharmacogenetic strategy is tacrolimus dosing based on the CYP3A5 genotype.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据